The Motley Fool

SaaS player MedAdvisor Ltd raises $17 million for growth push

Digital medication management company MedAdvisor Ltd (ASX: MDR) last week announced it has raised $17 million by issuing 340 million new shares at an issue price of 5 cents per share. That actually represented an 11% premium to its last pre-cap raising trading price of 4.5 cents per share.

Nasdaq-listed US healthcare operator HMS Holdings Corp (HMSY) is a cornerstone investor in the capital raising by agreeing to tip in $11 million.

“Funds raised will accelerate international expansion through MedAdvisor’s synergistic partnering strategies in the US, South East Asia and the UK, as well as driving domestic growth through sales, marketing and technology development taking the business towards cash break even,” Medadvisor reported. 

As part of the deal MedAdvisor also reports it will become HMS’s “preferred partner” for the distribution of digital health software-as-a-service products in the US and Australia. 

MedAdvisor claims to have connected more than 1 million patients already via a network of around 55% of all Australian pharmacies. 

For the fiscal year ending June 30 2019 it reported a net loss of $8.15 million on sales of $8.24 million and total revenue of  $9.2 million.

It recently recruited the ex Redbubble Ltd (ASX: RBL) chief technology officer to take up the role at MedAdvisor. 

As at September 2 2019 it had 1.37 billion shares on issue, with another 340 million issued as a result of the capital raising. As a result it looks to have a market value around $85 million based on around 1.71 billion shares on issue. 

NEW! Top 3 Dividend Bets for 2019

With interest rates likely to stay at rock bottom for months (or YEARS) to come, income-minded investors have nowhere to turn... except dividend shares. That’s why The Motley Fool’s top analysts have just prepared a brand-new report, laying out their top 3 dividend bets for 2019.

Hint: These are 3 shares you’ve probably never come across before.

They’re not the banks. Not Woolies or Wesfarmers or any of the “usual suspects.”

We think these 3 shares offer solid growth prospects over the next 12 months. Each of these three companies boasts fully franked yields and could be a great fit for your diversified portfolio. You’ll discover all three names and codes in "The Motley Fool’s Top 3 Dividend Shares for 2019."

Even better, your copy is free when you click the link below. Fair warning: This report is brand new and may not be available forever. Click the link below to be among the first investors to get access to this timely, important new research!

The names of these top 3 dividend bets are all included. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free copy right now!

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia has recommended MedAdvisor and REDBUBBLE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

FREE REPORT: Five Cheap and Good Stocks to Buy now…

Our Motley Fool experts have FREE report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.7% fully franked yield…

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.